Andrew Brett
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Andrew Brett has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Anand Murugasu
Department of Gastroenterology, The Royal Melbourne Hospital City Campus, Parkville, Victoria, Australia
1 shared publication- Angela Zhu
Department of Gastroenterology and Hepatology Alfred Health Melbourne Victoria Australia
1 shared publication - Belinda Liu
Department of Respiratory Medicine and Sleep Disorders, Royal Melbourne Hospital, Parkville, Victoria, Australia
1 shared publication Charlotte A. Slade
Immunology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
1 shared publication- Daniel Ng
Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Australia
1 shared publication Douglas Peter Tjandra
Department of Gastroenterology, The Royal Melbourne Hospital City Campus, Parkville, Victoria, Australia
1 shared publication
Latest Publications
- Open Access
- 28 September 2026
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 13 (10)
Gastrointestinal Manifestation of Light Chain Deposition Disease: Beware of the Snakeskin Duodenum
Gastrointestinal manifestations of light chain deposition disease are exceedingly rare and are characterized by gastrointestinal bleeding, nutritional deficiencies and protein-losing enteropathy. Diagnosis is challenging due to nonspecific symptomatology and indolent disease progression. We describe the case of a 69-year-old woman presenting with melena, chronic diarrhea, and recurrent sepsis. Gastroscopy revealed a highly unusual snakeskin appearance of the duodenum, with histopathology and immunofluorescence confirming light chain deposition disease. This case highlights the importance of prompt biopsy acquisition, hematological evaluation and assessment of extragastrointestinal involvement in facilitating a timely diagnosis, particularly when an underlying lymphoplasmacytic lymphoma is a possible driver of disease.
- 28 September 2026
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 13 (10)
Open AccessGastrointestinal Manifestation of Light Chain Deposition Disease: Beware of the Snakeskin Duodenum
Gastrointestinal manifestations of light chain deposition disease are exceedingly rare and are characterized by gastrointestinal bleeding, nutritional deficiencies and protein-losing enteropathy. Diagnosis is challenging due to nonspecific symptomatology and indolent disease progression. We describe the case of a 69-year-old woman presenting with melena, chronic diarrhea, and recurrent sepsis. Gastroscopy revealed a highly unusual snakeskin appearance of the duodenum, with histopathology and immunofluorescence confirming light chain deposition disease. This case highlights the importance of prompt biopsy acquisition, hematological evaluation and assessment of extragastrointestinal involvement in facilitating a timely diagnosis, particularly when an underlying lymphoplasmacytic lymphoma is a possible driver of disease.
- Open Access
- 27 February 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (8)
A dominant-negative IFNGR1 variant reveals broad immune cell sequestering of IFN-γ
A dominant-negative IFNGR1 variant reveals broad immune cell sequestering of IFN-γ
- 27 February 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (8)
Open AccessA dominant-negative IFNGR1 variant reveals broad immune cell sequestering of IFN-γ
A dominant-negative IFNGR1 variant reveals broad immune cell sequestering of IFN-γ
- 24 October 2023
- Published by BMJ in BMJ Case Reports
- Vol. 16 (10) , e256460
Use of bevacizumab in a patient with Whipple’s disease: managing diagnostic uncertainty
A man in his 30s with intellectual disability presented with 1 month of diarrhoea, weight loss and dyspnoea. Investigations were hampered due to significant anxiety. Laboratory tests detected microcytic anaemia and hypoalbuminaemia. CT demonstrated a fat-containing infiltrate in the mediastinum, mesentery and axillae, and pulmonary ground-glass infiltrates. Biopsy of the axilla showed cystic lymphatic malformations involving adipose tissue and lymph nodes, leading to a provisional diagnosis of generalised lymphatic anomaly. Over the subsequent 4 months, the patient’s respiratory status deteriorated, leading to type 1 respiratory failure necessitating intubation. After multidisciplinary discussion, a decision was made to trial bevacizumab, an anti-VEGF agent, with subsequent improvement in respiratory status. While intubated, gastroscopy was performed; duodenal biopsies revealed pathognomonic changes of Whipple’s disease, confirmed on PCR of duodenal and axillae biopsies. This was deemed the most likely unifying diagnosis; antibiotic treatment was commenced, bevacizumab was ceased, and the patient has remained well after 18 months.
- 24 October 2023
- Published by BMJ in BMJ Case Reports
- Vol. 16 (10) , e256460
Use of bevacizumab in a patient with Whipple’s disease: managing diagnostic uncertainty
A man in his 30s with intellectual disability presented with 1 month of diarrhoea, weight loss and dyspnoea. Investigations were hampered due to significant anxiety. Laboratory tests detected microcytic anaemia and hypoalbuminaemia. CT demonstrated a fat-containing infiltrate in the mediastinum, mesentery and axillae, and pulmonary ground-glass infiltrates. Biopsy of the axilla showed cystic lymphatic malformations involving adipose tissue and lymph nodes, leading to a provisional diagnosis of generalised lymphatic anomaly. Over the subsequent 4 months, the patient’s respiratory status deteriorated, leading to type 1 respiratory failure necessitating intubation. After multidisciplinary discussion, a decision was made to trial bevacizumab, an anti-VEGF agent, with subsequent improvement in respiratory status. While intubated, gastroscopy was performed; duodenal biopsies revealed pathognomonic changes of Whipple’s disease, confirmed on PCR of duodenal and axillae biopsies. This was deemed the most likely unifying diagnosis; antibiotic treatment was commenced, bevacizumab was ceased, and the patient has remained well after 18 months.